118 related articles for article (PubMed ID: 29944170)
1. Premature Aging Syndrome, Penttinen Type: Report of a Chinese Case with a PDGFRB Mutation.
Zhang Z; Zheng S; Zheng S; Wang Y; Xu XG; Gao XH; Chen HD
Acta Derm Venereol; 2018 Oct; 98(9):912-913. PubMed ID: 29944170
[No Abstract] [Full Text] [Related]
2. PDGFRB mutation causes autosomal-dominant Penttinen syndrome.
Aminkeng F
Clin Genet; 2015 Dec; 88(6):531. PubMed ID: 26507258
[TBL] [Abstract][Full Text] [Related]
3. First case report of Penttinen syndrome from India.
Aggarwal B; Correa ARE; Gupta N; Jana M; Kabra M
Am J Med Genet A; 2022 Feb; 188(2):683-687. PubMed ID: 34799960
[TBL] [Abstract][Full Text] [Related]
4. A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.
Bredrup C; Stokowy T; McGaughran J; Lee S; Sapkota D; Cristea I; Xu L; Tveit KS; Høvding G; Steen VM; Rødahl E; Bruland O; Houge G
Eur J Hum Genet; 2019 Apr; 27(4):574-581. PubMed ID: 30573803
[TBL] [Abstract][Full Text] [Related]
5. A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.
Johnston JJ; Sanchez-Contreras MY; Keppler-Noreuil KM; Sapp J; Crenshaw M; Finch NA; Cormier-Daire V; Rademakers R; Sybert VP; Biesecker LG
Am J Hum Genet; 2015 Sep; 97(3):465-74. PubMed ID: 26279204
[TBL] [Abstract][Full Text] [Related]
6. Expansion of the phenotype of Kosaki overgrowth syndrome.
Minatogawa M; Takenouchi T; Tsuyusaki Y; Iwasaki F; Uehara T; Kurosawa K; Kosaki K; Curry CJ
Am J Med Genet A; 2017 Sep; 173(9):2422-2427. PubMed ID: 28639748
[TBL] [Abstract][Full Text] [Related]
7. Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions.
Bredrup C; Cristea I; Safieh LA; Di Maria E; Gjertsen BT; Tveit KS; Thu F; Bull N; Edward DP; Hennekam RCM; Høvding G; Haugen OH; Houge G; Rødahl E; Bruland O
Hum Mol Genet; 2021 Mar; 30(1):72-77. PubMed ID: 33450762
[TBL] [Abstract][Full Text] [Related]
8. The Master of Puppets: Pleiotropy of PDGFRB and its Relationship to Multiple Diseases.
Moura DAP; de Oliveira JRM
J Mol Neurosci; 2020 Dec; 70(12):2102-2106. PubMed ID: 32613555
[TBL] [Abstract][Full Text] [Related]
9. Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling.
Nédélec A; Guérit EM; Dachy G; Lenglez S; Wong LS; Arts FA; Demoulin JB
J Cell Mol Med; 2022 Jul; 26(14):3902-3912. PubMed ID: 35689379
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome.
Iznardo H; Bredrup C; Bernal S; Gladkauskas T; Mascaró JM; Roé E; Baselga E
Am J Med Genet A; 2022 Apr; 188(4):1233-1238. PubMed ID: 34894066
[TBL] [Abstract][Full Text] [Related]
11. Acro-osteolysis, keloid like-lesions, distinctive facial features, and overgrowth: two newly recognized patients with premature aging syndrome, Penttinen type.
Zufferey F; Hadj-Rabia S; De Sandre-Giovannoli A; Dufier JL; Leheup B; Schweitze C; Bodemer C; Cormier-Daire V; Le Merrer M
Am J Med Genet A; 2013 Jul; 161A(7):1786-91. PubMed ID: 23720404
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.
Lepelletier C; Al-Sarraj Y; Bodemer C; Shaath H; Fraitag S; Kambouris M; Hamel-Teillac D; El Shanti H; Hadj-Rabia S
Acta Derm Venereol; 2017 Jul; 97(7):858-859. PubMed ID: 28417142
[No Abstract] [Full Text] [Related]
13. Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys).
Chenbhanich J; Hu Y; Hetts S; Cooke D; Dowd C; Devine P; ; Russell B; Kang SHL; Chang VY; Abla AA; Cornett P; Yeh I; Lee H; Martinez-Agosto JA; Frieden IJ; Shieh JT
Am J Med Genet A; 2021 May; 185(5):1430-1436. PubMed ID: 33683022
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural skin changes in Egyptian mandibuloacral dysplasia patients with p.Arg527Leu LMNA mutation and in their asymptomatic heterozygotic mothers.
Al-Haggar M; Shams A; Madej-Pilarczyk A; Barakat T; Puzianowska-Kuznicka M
J Clin Pathol; 2013 Nov; 66(11):1000-4. PubMed ID: 23775434
[No Abstract] [Full Text] [Related]
15. Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta.
Takenouchi T; Okuno H; Kosaki K
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):650-657. PubMed ID: 31710779
[TBL] [Abstract][Full Text] [Related]
16. CHILD syndrome: effective treatment of ichthyosiform naevus with oral and topical ketoconazole.
Liu T; Qian G; Wang XX; Zhang YG
Acta Derm Venereol; 2015 Jan; 95(1):91-2. PubMed ID: 24696032
[No Abstract] [Full Text] [Related]
17. Hutchinson-Gilford progeria syndrome caused by an LMNA mutation: a case report.
Chu Y; Xu ZG; Xu Z; Ma L
Pediatr Dermatol; 2015; 32(2):271-5. PubMed ID: 25556323
[TBL] [Abstract][Full Text] [Related]
18. Novel ADAMTSL2-mutations in a patient with geleophysic dysplasia type I.
Mackenroth L; Rump A; Lorenz P; Schröck E; Tzschach A
Clin Dysmorphol; 2016 Jul; 25(3):106-9. PubMed ID: 27057656
[No Abstract] [Full Text] [Related]
19. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis.
Guimier A; Gordon CT; Hully M; Blauwblomme T; Minard-Colin V; Bole-Feysot C; Nitschké P; Oufadem M; Boddaert N; Sarnacki S; Amiel J
Am J Med Genet A; 2019 Jul; 179(7):1304-1309. PubMed ID: 31004414
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility gene card for: Peters plus syndrome.
Jaeken J; Lefeber DJ; Matthijs G
Eur J Hum Genet; 2016 Aug; 24(8):. PubMed ID: 27049305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
